Literature DB >> 11822795

Swedish population health-related quality of life results using the EQ-5D.

K Burström1, M Johannesson, F Diderichsen.   

Abstract

Health-related quality of life (HRQoL) measured on population level may be useful to guide policies for health. This study aims to describe the HRQoL; in EQ-5D dimensions, mean rating scale (RS) scores and mean EQ-5D index values, in the general population, by certain disease and socio-economic groups, in Stockholm County 1998. The EQ-5D self-classifier and a RS were included in the 1998 cross-sectional postal Stockholm County public health survey to a representative sample (n = 4950, 20-88 years), 63% response rate. Mean RS score ranged from 0.90 (20-29 years) to 0.69 (80-88 years), mean EQ-5D index value ranged from 0.89 (20-29 years) to 0.74 (80-88 years). For different diseases mean RS scores ranged from 0.80 (asthma) to 0.69 (angina pectoris), mean EQ-5D index values ranged from 0.79 (asthma) to 0.66 (low back pain). The mean health state scores (RS and EQ-5D index) were 0.06 lower in the unskilled manual group than in the higher non-manual group after controlling for age and sex (p < 0.0001). This difference was 0.03 after controlling also for different diseases (p < 0.0001). In conclusion, our results show that the HRQoL varies greatly between socio-economic and disease groups. Furthermore, after controlling for age, sex and disease, HRQoL is lower in manual than in non-manual groups.

Entities:  

Mesh:

Year:  2001        PMID: 11822795     DOI: 10.1023/a:1013171831202

Source DB:  PubMed          Journal:  Qual Life Res        ISSN: 0962-9343            Impact factor:   4.147


  25 in total

1.  Comparison of the EQ-5D and SF-12 health surveys in a general population survey in Alberta, Canada.

Authors:  J A Johnson; A S Pickard
Journal:  Med Care       Date:  2000-01       Impact factor: 2.983

2.  The relationship between health-state utilities and the SF-12 in a general population.

Authors:  L Lundberg; M Johannesson; D G Isacson; L Borgquist
Journal:  Med Decis Making       Date:  1999 Apr-Jun       Impact factor: 2.583

3.  Valuation of EuroQOL (EQ-5D) health states in an adult US sample.

Authors:  J A Johnson; S J Coons; A Ergo; G Szava-Kovats
Journal:  Pharmacoeconomics       Date:  1998-04       Impact factor: 4.981

Review 4.  EuroQol: the current state of play.

Authors:  R Brooks
Journal:  Health Policy       Date:  1996-07       Impact factor: 2.980

5.  EuroQol: health-related quality of life measurement. Valuations of health states by the general public in Norway.

Authors:  E Nord
Journal:  Health Policy       Date:  1991-06       Impact factor: 2.980

6.  Valuation of health states by the general public: feasibility of a standardized measurement procedure.

Authors:  M L Essink-Bot; G J Bonsel; P J van der Maas
Journal:  Soc Sci Med       Date:  1990       Impact factor: 4.634

7.  Variations in population health status: results from a United Kingdom national questionnaire survey.

Authors:  P Kind; P Dolan; C Gudex; A Williams
Journal:  BMJ       Date:  1998-03-07

8.  Some reflections on cost-effectiveness analysis.

Authors:  M Johannesson; D Meltzer
Journal:  Health Econ       Date:  1998-02       Impact factor: 3.046

9.  Determining a minimal important change in a disease-specific Quality of Life Questionnaire.

Authors:  E F Juniper; G H Guyatt; A Willan; L E Griffith
Journal:  J Clin Epidemiol       Date:  1994-01       Impact factor: 6.437

10.  EuroQol: health-related quality of life measurement. Results of the Swedish questionnaire exercise.

Authors:  R G Brooks; S Jendteg; B Lindgren; U Persson; S Björk
Journal:  Health Policy       Date:  1991-06       Impact factor: 2.980

View more
  205 in total

1.  Population norms for the EQ-5D index scores using Singapore preference weights.

Authors:  Edimansyah Abdin; Mythily Subramaniam; Janhavi Ajit Vaingankar; Nan Luo; Siow Ann Chong
Journal:  Qual Life Res       Date:  2014-11-14       Impact factor: 4.147

2.  Cost-effectiveness of bazedoxifene incorporating the FRAX® algorithm in a European perspective.

Authors:  F Borgström; O Ström; M Kleman; E McCloskey; H Johansson; A Odén; J A Kanis
Journal:  Osteoporos Int       Date:  2010-06-08       Impact factor: 4.507

3.  Do Portuguese and UK health state values differ across valuation methods?

Authors:  Lara N Ferreira; Pedro L Ferreira; Donna Rowen; John E Brazier
Journal:  Qual Life Res       Date:  2011-05       Impact factor: 4.147

4.  Responsiveness of the Short Musculoskeletal Function Assessment (SMFA) in patients with femoral neck fractures.

Authors:  Carl Johan Hedbeck; Jan Tidermark; Sari Ponzer; Richard Blomfeldt; Gunnar Bergström
Journal:  Qual Life Res       Date:  2010-11-12       Impact factor: 4.147

5.  Preference-based health-related quality of life among victims of bullying.

Authors:  Linda Beckman; Mikael Svensson; Ann Frisén
Journal:  Qual Life Res       Date:  2015-08-14       Impact factor: 4.147

Review 6.  Health related quality of life outcome instruments.

Authors:  Gunnar Németh
Journal:  Eur Spine J       Date:  2005-12-01       Impact factor: 3.134

7.  Relationship among sociodemographic factors, clinical conditions, and health-related quality of life: examining the EQ-5D in the U.S. general population.

Authors:  Erica I Lubetkin; Haomiao Jia; Peter Franks; Marthe R Gold
Journal:  Qual Life Res       Date:  2005-12       Impact factor: 4.147

8.  EQ-5D in a general population survey--a description of the most commonly reported EQ-5D health states using the SF-36.

Authors:  A Nordlund; K Ekberg; M Kristenson
Journal:  Qual Life Res       Date:  2005-05       Impact factor: 4.147

9.  Incorporating quality of evidence into decision analytic modeling.

Authors:  R Scott Braithwaite; Mark S Roberts; Amy C Justice
Journal:  Ann Intern Med       Date:  2007-01-16       Impact factor: 25.391

10.  The impact of 29 chronic conditions on health-related quality of life: a general population survey in Finland using 15D and EQ-5D.

Authors:  Samuli I Saarni; Tommi Härkänen; Harri Sintonen; Jaana Suvisaari; Seppo Koskinen; Arpo Aromaa; Jouko Lönnqvist
Journal:  Qual Life Res       Date:  2006-09-08       Impact factor: 4.147

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.